.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Accenture
McKesson
Daiichi Sankyo
Healthtrust
Citi
Medtronic
Colorcon
Chubb

Generated: June 27, 2017

DrugPatentWatch Database Preview

TIVORBEX Drug Profile

« Back to Dashboard

Which patents cover Tivorbex, and what generic Tivorbex alternatives are available?

Tivorbex is a drug marketed by Iroko Pharms Llc and is included in one NDA. There are three patents protecting this drug.

This drug has thirty-two patent family members in eighteen countries.

The generic ingredient in TIVORBEX is indomethacin. There are fifteen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the indomethacin profile page.

Summary for Tradename: TIVORBEX

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list91
Patent Applications: see list8,932
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TIVORBEX at DailyMed

Pharmacology for Tradename: TIVORBEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms Llc
TIVORBEX
indomethacin
CAPSULE;ORAL204768-001Feb 24, 2014RXYesNo8,734,847► SubscribeY ► Subscribe
Iroko Pharms Llc
TIVORBEX
indomethacin
CAPSULE;ORAL204768-002Feb 24, 2014RXYesYes9,089,471► Subscribe ► Subscribe
Iroko Pharms Llc
TIVORBEX
indomethacin
CAPSULE;ORAL204768-001Feb 24, 2014RXYesNo► Subscribe► Subscribe
Iroko Pharms Llc
TIVORBEX
indomethacin
CAPSULE;ORAL204768-002Feb 24, 2014RXYesYes► Subscribe► Subscribe
Iroko Pharms Llc
TIVORBEX
indomethacin
CAPSULE;ORAL204768-001Feb 24, 2014RXYesNo8,992,982► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: TIVORBEX

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,095,496Formulation of indomethacin► Subscribe
9,522,135Formulation of indomethacin► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TIVORBEX

Country Document Number Estimated Expiration
African Regional IP Organization (ARIPO)201508955► Subscribe
Singapore175315► Subscribe
Japan6043329► Subscribe
China102438594► Subscribe
South Africa201108646► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Novartis
Farmers Insurance
Moodys
Julphar
Teva
Daiichi Sankyo
US Department of Justice
Cerilliant
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot